179 related articles for article (PubMed ID: 26018509)
1. miR-106a* inhibits the proliferation of renal carcinoma cells by targeting IRS-2.
Ma Y; Zhang H; He X; Song H; Qiang Y; Li Y; Gao J; Wang Z
Tumour Biol; 2015 Nov; 36(11):8389-98. PubMed ID: 26018509
[TBL] [Abstract][Full Text] [Related]
2. MiR-144 inhibits cell proliferation of renal cell carcinoma by targeting MTOR.
Xiang C; Cui SP; Ke Y
J Huazhong Univ Sci Technolog Med Sci; 2016 Apr; 36(2):186-192. PubMed ID: 27072960
[TBL] [Abstract][Full Text] [Related]
3. miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells.
Liu Y; Zhang M; Qian J; Bao M; Meng X; Zhang S; Zhang L; Zhao R; Li S; Cao Q; Li P; Ju X; Lu Q; Li J; Shao P; Qin C; Yin C
DNA Cell Biol; 2015 Jun; 34(6):429-36. PubMed ID: 25811077
[TBL] [Abstract][Full Text] [Related]
4. miR-106a* inhibits the proliferation of esophageal carcinoma cells by targeting CDK2-associated Cullin 1 (CACUL1).
Ma HL; Wen XP; Zhang XZ; Wang XL; Zhao DL; Che SM; Dang CX
Cell Mol Biol (Noisy-le-grand); 2015 Aug; 61(4):56-62. PubMed ID: 26314198
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y
Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776
[TBL] [Abstract][Full Text] [Related]
6. MiR-30a suppresses non-small cell lung cancer progression through AKT signaling pathway by targeting IGF1R.
Wen XP; Ma HL; Zhao LY; Zhang W; Dang CX
Cell Mol Biol (Noisy-le-grand); 2015 May; 61(2):78-85. PubMed ID: 26025408
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-561 Affects Proliferation and Cell Cycle Transition Through PTEN/AKT Signaling Pathway by Targeting P-REX2a in NSCLC.
Liao Z; Zheng Q; Wei T; Zhang Y; Ma J; Zhao Z; Sun H; Nan K
Oncol Res; 2020 Mar; 28(2):147-159. PubMed ID: 31711559
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR-493 promoted melanoma proliferation by suppressing IRS4 expression.
Cui A; Jin Z; Gao Z; Jin M; Zhu L; Li L; Jin C; An Y
Tumour Biol; 2017 May; 39(5):1010428317701640. PubMed ID: 28475006
[TBL] [Abstract][Full Text] [Related]
9. MiR-7 regulates the PI3K/AKT/VEGF pathway of retinal capillary endothelial cell and retinal pericytes in diabetic rat model through IRS-1 and inhibits cell proliferation.
Cao YL; Liu DJ; Zhang HG
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4427-4430. PubMed ID: 30058674
[TBL] [Abstract][Full Text] [Related]
10. Kinesin Motor Protein KIFC1 Is a Target Protein of miR-338-3p and Is Associated With Poor Prognosis and Progression of Renal Cell Carcinoma.
Li G; Chong T; Yang J; Li H; Chen H
Oncol Res; 2018 Dec; 27(1):125-137. PubMed ID: 29562961
[TBL] [Abstract][Full Text] [Related]
11. MiR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5.
Pan YJ; Wei LL; Wu XJ; Huo FC; Mou J; Pei DS
Cell Death Dis; 2017 Oct; 8(10):e3155. PubMed ID: 29072688
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of serum microRNAs miR-21 and miR-106a in renal cell carcinoma.
Tusong H; Maolakuerban N; Guan J; Rexiati M; Wang WG; Azhati B; Nuerrula Y; Wang YJ
Cancer Biomark; 2017; 18(1):79-85. PubMed ID: 27814278
[TBL] [Abstract][Full Text] [Related]
13. MiR-193a-3p and miR-224 mediate renal cell carcinoma progression by targeting alpha-2,3-sialyltransferase IV and the phosphatidylinositol 3 kinase/Akt pathway.
Pan Y; Hu J; Ma J; Qi X; Zhou H; Miao X; Zheng W; Jia L
Mol Carcinog; 2018 Aug; 57(8):1067-1077. PubMed ID: 29667779
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway.
Nie ZC; Weng WH; Shang YS; Long Y; Li J; Xu YT; Li Z
Int J Clin Exp Pathol; 2015; 8(5):4745-54. PubMed ID: 26191164
[TBL] [Abstract][Full Text] [Related]
15. Depletion of the triggering receptor expressed on myeloid cells 2 inhibits progression of renal cell carcinoma via regulating related protein expression and PTEN-PI3K/Akt pathway.
Zhang H; Sheng L; Tao J; Chen R; Li Y; Sun Z; Qian W
Int J Oncol; 2016 Dec; 49(6):2498-2506. PubMed ID: 27779645
[TBL] [Abstract][Full Text] [Related]
16. miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B.
Wang C; Wu C; Yang Q; Ding M; Zhong J; Zhang CY; Ge J; Wang J; Zhang C
Oncotarget; 2016 Nov; 7(45):73888-73902. PubMed ID: 27729617
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-186 Suppresses Cell Proliferation and Metastasis Through Targeting Sentrin-Specific Protease 1 in Renal Cell Carcinoma.
Jiao D; Wu M; Ji L; Liu F; Liu Y
Oncol Res; 2018 Mar; 26(2):249-259. PubMed ID: 28550686
[TBL] [Abstract][Full Text] [Related]
18. miR-206 inhibits renal cell cancer growth by targeting GAK.
Wei C; Wang S; Ye ZQ; Chen ZQ
J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):852-858. PubMed ID: 27924503
[TBL] [Abstract][Full Text] [Related]
19. High Annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinoma.
Tang J; Qin Z; Han P; Wang W; Yang C; Xu Z; Li R; Liu B; Qin C; Wang Z; Tang M; Zhang W
Int J Oncol; 2017 May; 50(5):1839-1847. PubMed ID: 28393205
[TBL] [Abstract][Full Text] [Related]
20. Targeted p21(WAF1/CIP1) activation by miR-1236 inhibits cell proliferation and correlates with favorable survival in renal cell carcinoma.
Wang C; Tang K; Li Z; Chen Z; Xu H; Ye Z
Urol Oncol; 2016 Feb; 34(2):59.e23-34. PubMed ID: 26421587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]